| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Plaque, Atherosclerotic | 10 | 2023 | 152 | 3.750 |
Why?
|
| Tomography, Optical Coherence | 22 | 2023 | 490 | 3.630 |
Why?
|
| Vascular Calcification | 4 | 2024 | 71 | 2.460 |
Why?
|
| Coronary Vessels | 16 | 2023 | 547 | 2.330 |
Why?
|
| Coronary Artery Disease | 9 | 2024 | 891 | 2.160 |
Why?
|
| Lithotripsy | 2 | 2024 | 30 | 1.690 |
Why?
|
| Percutaneous Coronary Intervention | 4 | 2023 | 302 | 1.530 |
Why?
|
| Fractional Flow Reserve, Myocardial | 2 | 2021 | 55 | 1.200 |
Why?
|
| Macrophages | 5 | 2015 | 691 | 1.060 |
Why?
|
| Stroke Volume | 5 | 2021 | 535 | 1.000 |
Why?
|
| Peripheral Arterial Disease | 5 | 2022 | 320 | 0.920 |
Why?
|
| Edetic Acid | 1 | 2024 | 23 | 0.880 |
Why?
|
| Gold | 4 | 2012 | 56 | 0.870 |
Why?
|
| Fractures, Stress | 1 | 2023 | 14 | 0.840 |
Why?
|
| Myocardial Infarction | 2 | 2023 | 1044 | 0.830 |
Why?
|
| Lithotripsy, Laser | 1 | 2023 | 19 | 0.830 |
Why?
|
| Cardiologists | 1 | 2023 | 25 | 0.830 |
Why?
|
| Heart Ventricles | 6 | 2024 | 782 | 0.810 |
Why?
|
| Heart | 4 | 2020 | 687 | 0.790 |
Why?
|
| Diastole | 3 | 2019 | 181 | 0.770 |
Why?
|
| Atherectomy, Coronary | 1 | 2022 | 10 | 0.740 |
Why?
|
| Coronary Stenosis | 1 | 2021 | 83 | 0.660 |
Why?
|
| Ventricular Function, Left | 6 | 2021 | 545 | 0.650 |
Why?
|
| Predictive Value of Tests | 10 | 2023 | 2311 | 0.630 |
Why?
|
| Compliance | 1 | 2019 | 18 | 0.620 |
Why?
|
| Heart-Assist Devices | 2 | 2024 | 1066 | 0.560 |
Why?
|
| Microscopy, Phase-Contrast | 2 | 2015 | 15 | 0.560 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2017 | 56 | 0.520 |
Why?
|
| Stents | 6 | 2018 | 868 | 0.510 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2015 | 8 | 0.480 |
Why?
|
| Refractometry | 1 | 2015 | 9 | 0.480 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2018 | 119 | 0.480 |
Why?
|
| Scattering, Radiation | 4 | 2016 | 56 | 0.450 |
Why?
|
| Absorbable Implants | 1 | 2014 | 26 | 0.440 |
Why?
|
| Defibrillators, Implantable | 1 | 2017 | 203 | 0.440 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 742 | 0.440 |
Why?
|
| Light | 4 | 2016 | 183 | 0.430 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2014 | 63 | 0.420 |
Why?
|
| Myocardial Contraction | 3 | 2006 | 254 | 0.420 |
Why?
|
| Pacemaker, Artificial | 3 | 2021 | 187 | 0.420 |
Why?
|
| Treatment Outcome | 10 | 2024 | 12987 | 0.420 |
Why?
|
| Artifacts | 1 | 2014 | 114 | 0.420 |
Why?
|
| Reproducibility of Results | 7 | 2017 | 3008 | 0.390 |
Why?
|
| Endovascular Procedures | 3 | 2018 | 785 | 0.390 |
Why?
|
| Toxicity Tests | 1 | 2012 | 35 | 0.390 |
Why?
|
| Electric Power Supplies | 3 | 2021 | 19 | 0.380 |
Why?
|
| Femoral Artery | 3 | 2019 | 166 | 0.380 |
Why?
|
| Cell Tracking | 1 | 2012 | 17 | 0.370 |
Why?
|
| Metal Nanoparticles | 1 | 2012 | 56 | 0.370 |
Why?
|
| Tachycardia, Ventricular | 1 | 2014 | 211 | 0.370 |
Why?
|
| Coronary Angiography | 5 | 2023 | 484 | 0.370 |
Why?
|
| Nanoparticles | 2 | 2012 | 289 | 0.350 |
Why?
|
| X-Ray Microtomography | 3 | 2023 | 95 | 0.340 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 363 | 0.330 |
Why?
|
| Humans | 33 | 2024 | 132013 | 0.330 |
Why?
|
| Swine | 5 | 2021 | 1178 | 0.320 |
Why?
|
| Iron | 1 | 2012 | 302 | 0.310 |
Why?
|
| Animals | 20 | 2021 | 34804 | 0.310 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2023 | 119 | 0.300 |
Why?
|
| Calcium | 2 | 2023 | 1079 | 0.290 |
Why?
|
| Myocardium | 4 | 2019 | 906 | 0.290 |
Why?
|
| Drug-Eluting Stents | 3 | 2019 | 69 | 0.290 |
Why?
|
| Hemodynamics | 4 | 2019 | 849 | 0.270 |
Why?
|
| Heart Failure | 2 | 2019 | 2371 | 0.270 |
Why?
|
| Algorithms | 4 | 2020 | 1718 | 0.260 |
Why?
|
| Systole | 3 | 2019 | 205 | 0.250 |
Why?
|
| Cardiovascular Diseases | 2 | 2009 | 2088 | 0.250 |
Why?
|
| Brachiocephalic Trunk | 1 | 2006 | 39 | 0.250 |
Why?
|
| Phantoms, Imaging | 3 | 2014 | 133 | 0.240 |
Why?
|
| Mice, Inbred C57BL | 7 | 2015 | 4757 | 0.240 |
Why?
|
| Time Factors | 8 | 2022 | 6441 | 0.230 |
Why?
|
| Vascular Resistance | 1 | 2006 | 195 | 0.230 |
Why?
|
| Heart Conduction System | 1 | 2006 | 156 | 0.230 |
Why?
|
| Atherosclerosis | 3 | 2009 | 1007 | 0.230 |
Why?
|
| Paclitaxel | 2 | 2019 | 140 | 0.220 |
Why?
|
| Calcium Chelating Agents | 1 | 2024 | 1 | 0.220 |
Why?
|
| Electrodes | 1 | 2024 | 91 | 0.220 |
Why?
|
| Cells, Cultured | 4 | 2015 | 3043 | 0.210 |
Why?
|
| Multimodal Imaging | 2 | 2015 | 110 | 0.210 |
Why?
|
| Atherectomy | 2 | 2022 | 12 | 0.210 |
Why?
|
| Cardiology | 1 | 2009 | 498 | 0.210 |
Why?
|
| Models, Cardiovascular | 4 | 2024 | 183 | 0.210 |
Why?
|
| Titanium | 3 | 2008 | 26 | 0.210 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2023 | 44 | 0.210 |
Why?
|
| Arteriovenous Fistula | 1 | 2023 | 55 | 0.200 |
Why?
|
| Aneurysm, False | 1 | 2023 | 92 | 0.190 |
Why?
|
| Shock, Cardiogenic | 1 | 2023 | 176 | 0.190 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2018 | 288 | 0.180 |
Why?
|
| Mice | 10 | 2019 | 18478 | 0.180 |
Why?
|
| Neointima | 3 | 2019 | 47 | 0.180 |
Why?
|
| Equipment Design | 2 | 2015 | 599 | 0.170 |
Why?
|
| Ultrasonography, Interventional | 2 | 2020 | 207 | 0.170 |
Why?
|
| Combined Modality Therapy | 1 | 2024 | 1294 | 0.170 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2016 | 227 | 0.170 |
Why?
|
| Angioplasty, Balloon | 2 | 2019 | 156 | 0.160 |
Why?
|
| Finite Element Analysis | 2 | 2024 | 35 | 0.160 |
Why?
|
| Rabbits | 2 | 2019 | 673 | 0.160 |
Why?
|
| Hypotension | 1 | 2021 | 185 | 0.160 |
Why?
|
| Hemorrhage | 1 | 2023 | 518 | 0.160 |
Why?
|
| Prosthesis Design | 4 | 2019 | 665 | 0.160 |
Why?
|
| Self Expandable Metallic Stents | 1 | 2019 | 8 | 0.160 |
Why?
|
| Vascular Patency | 1 | 2019 | 188 | 0.150 |
Why?
|
| Aged | 10 | 2023 | 21406 | 0.150 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 2139 | 0.150 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2019 | 66 | 0.150 |
Why?
|
| Drug Delivery Systems | 3 | 2010 | 223 | 0.150 |
Why?
|
| Cardiovascular Agents | 1 | 2019 | 87 | 0.140 |
Why?
|
| Dogs | 2 | 2021 | 652 | 0.140 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2008 | 36 | 0.140 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2018 | 49 | 0.140 |
Why?
|
| Drug Carriers | 2 | 2010 | 119 | 0.140 |
Why?
|
| Female | 15 | 2023 | 70643 | 0.140 |
Why?
|
| Fibrosis | 2 | 2016 | 421 | 0.140 |
Why?
|
| Microcirculation | 1 | 2018 | 117 | 0.130 |
Why?
|
| Male | 13 | 2023 | 64914 | 0.130 |
Why?
|
| Laser Therapy | 1 | 2019 | 232 | 0.130 |
Why?
|
| Nanostructures | 2 | 2008 | 63 | 0.130 |
Why?
|
| Aspirin | 1 | 2018 | 220 | 0.120 |
Why?
|
| Pharmaceutical Preparations | 2 | 2008 | 89 | 0.120 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 4684 | 0.120 |
Why?
|
| Cadaver | 1 | 2016 | 119 | 0.120 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2019 | 374 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 2 | 2015 | 326 | 0.120 |
Why?
|
| Angina, Stable | 1 | 2015 | 8 | 0.120 |
Why?
|
| Equipment Failure Analysis | 1 | 2015 | 83 | 0.120 |
Why?
|
| Luminescent Measurements | 1 | 2015 | 60 | 0.120 |
Why?
|
| Glioblastoma | 1 | 2019 | 373 | 0.120 |
Why?
|
| Blood Physiological Phenomena | 1 | 2014 | 4 | 0.110 |
Why?
|
| Mice, Mutant Strains | 2 | 2006 | 377 | 0.110 |
Why?
|
| Tomography, Optical | 1 | 2014 | 7 | 0.110 |
Why?
|
| Metals | 1 | 2014 | 66 | 0.110 |
Why?
|
| Lasers | 1 | 2014 | 117 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2004 | 1411 | 0.110 |
Why?
|
| Alloys | 2 | 2019 | 15 | 0.100 |
Why?
|
| Thrombosis | 1 | 2018 | 523 | 0.100 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2021 | 1173 | 0.100 |
Why?
|
| Solutions | 1 | 2012 | 58 | 0.100 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2012 | 44 | 0.100 |
Why?
|
| Acids | 1 | 2012 | 31 | 0.100 |
Why?
|
| Biopsy | 1 | 2016 | 1284 | 0.100 |
Why?
|
| Injections, Intravenous | 1 | 2012 | 247 | 0.090 |
Why?
|
| Infrared Rays | 1 | 2012 | 23 | 0.090 |
Why?
|
| Acute Coronary Syndrome | 1 | 2015 | 244 | 0.090 |
Why?
|
| Rupture, Spontaneous | 2 | 2015 | 47 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 602 | 0.090 |
Why?
|
| Heart Rate | 2 | 2006 | 584 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2012 | 448 | 0.090 |
Why?
|
| Inflammation | 1 | 2019 | 1519 | 0.090 |
Why?
|
| Medical Records | 1 | 2012 | 189 | 0.090 |
Why?
|
| Middle Aged | 8 | 2019 | 28968 | 0.080 |
Why?
|
| Chromium Alloys | 1 | 2010 | 1 | 0.080 |
Why?
|
| Spectrophotometry | 1 | 2009 | 56 | 0.080 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 1404 | 0.080 |
Why?
|
| Polymers | 1 | 2010 | 108 | 0.080 |
Why?
|
| Prostheses and Implants | 2 | 2021 | 152 | 0.070 |
Why?
|
| Feasibility Studies | 2 | 2015 | 819 | 0.070 |
Why?
|
| Contrast Media | 2 | 2009 | 507 | 0.070 |
Why?
|
| Ferric Compounds | 1 | 2008 | 41 | 0.070 |
Why?
|
| Brachytherapy | 1 | 2009 | 95 | 0.070 |
Why?
|
| Stainless Steel | 1 | 2008 | 6 | 0.070 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2007 | 23 | 0.070 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2007 | 39 | 0.070 |
Why?
|
| Transcription Factor AP-1 | 1 | 2007 | 110 | 0.070 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2007 | 125 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 142 | 0.070 |
Why?
|
| Drug Implants | 1 | 2006 | 45 | 0.060 |
Why?
|
| Interleukin-17 | 1 | 2007 | 129 | 0.060 |
Why?
|
| Pharmaceutical Vehicles | 1 | 2006 | 2 | 0.060 |
Why?
|
| Interleukin-18 | 1 | 2007 | 68 | 0.060 |
Why?
|
| Cardiomegaly | 1 | 2007 | 124 | 0.060 |
Why?
|
| Blood Volume | 1 | 2006 | 80 | 0.060 |
Why?
|
| Electrophysiology | 1 | 2006 | 268 | 0.060 |
Why?
|
| Apolipoproteins E | 1 | 2006 | 200 | 0.060 |
Why?
|
| Retrospective Studies | 1 | 2023 | 17374 | 0.060 |
Why?
|
| Temperature | 1 | 2006 | 302 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2023 | 6568 | 0.060 |
Why?
|
| NF-kappa B | 1 | 2007 | 454 | 0.060 |
Why?
|
| Porosity | 2 | 2020 | 43 | 0.060 |
Why?
|
| Microscopy, Atomic Force | 3 | 2010 | 20 | 0.060 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2006 | 145 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 1160 | 0.050 |
Why?
|
| Radial Artery | 1 | 2023 | 33 | 0.050 |
Why?
|
| In Vitro Techniques | 2 | 2015 | 862 | 0.050 |
Why?
|
| Printing, Three-Dimensional | 1 | 2024 | 68 | 0.050 |
Why?
|
| Cardiac Volume | 1 | 2003 | 18 | 0.050 |
Why?
|
| Aorta | 2 | 2007 | 550 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2007 | 861 | 0.050 |
Why?
|
| Hematoma | 1 | 2023 | 92 | 0.050 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2006 | 515 | 0.050 |
Why?
|
| Vena Cava, Inferior | 1 | 2003 | 105 | 0.050 |
Why?
|
| Blood Substitutes | 1 | 2002 | 8 | 0.050 |
Why?
|
| Species Specificity | 1 | 2003 | 541 | 0.050 |
Why?
|
| Interferometry | 1 | 2002 | 24 | 0.050 |
Why?
|
| Tomography | 1 | 2002 | 34 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2006 | 606 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2007 | 3865 | 0.040 |
Why?
|
| Ventricular Function, Right | 1 | 2002 | 119 | 0.040 |
Why?
|
| Electronics | 1 | 2021 | 45 | 0.040 |
Why?
|
| Motion | 1 | 2021 | 44 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2015 | 1441 | 0.040 |
Why?
|
| Micro-Electrical-Mechanical Systems | 1 | 2020 | 3 | 0.040 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2020 | 13 | 0.040 |
Why?
|
| Zinc Oxide | 1 | 2020 | 13 | 0.040 |
Why?
|
| Nanotubes, Carbon | 1 | 2020 | 20 | 0.040 |
Why?
|
| Body Weight | 1 | 2004 | 994 | 0.040 |
Why?
|
| Models, Animal | 1 | 2021 | 468 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2023 | 661 | 0.040 |
Why?
|
| Surface Properties | 2 | 2010 | 93 | 0.040 |
Why?
|
| Vascular Remodeling | 1 | 2019 | 54 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2019 | 271 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2019 | 382 | 0.040 |
Why?
|
| Spectrum Analysis | 2 | 2008 | 66 | 0.040 |
Why?
|
| Walk Test | 1 | 2018 | 28 | 0.040 |
Why?
|
| Ankle Brachial Index | 1 | 2018 | 45 | 0.040 |
Why?
|
| Hypertension | 1 | 2007 | 1396 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2003 | 1400 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2008 | 351 | 0.030 |
Why?
|
| Europe | 1 | 2018 | 372 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2017 | 170 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2018 | 461 | 0.030 |
Why?
|
| Blood Circulation | 1 | 2014 | 17 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 1177 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 588 | 0.030 |
Why?
|
| Angiography | 1 | 2014 | 208 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 713 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 376 | 0.020 |
Why?
|
| Coronary Thrombosis | 1 | 2012 | 35 | 0.020 |
Why?
|
| Tunica Intima | 1 | 2012 | 55 | 0.020 |
Why?
|
| International Cooperation | 1 | 2012 | 166 | 0.020 |
Why?
|
| Reference Standards | 1 | 2012 | 242 | 0.020 |
Why?
|
| Photoelectron Spectroscopy | 1 | 2010 | 7 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2010 | 136 | 0.020 |
Why?
|
| Flufenamic Acid | 1 | 2008 | 1 | 0.020 |
Why?
|
| Esterification | 1 | 2008 | 13 | 0.020 |
Why?
|
| Magnetics | 1 | 2008 | 37 | 0.020 |
Why?
|
| Buffers | 1 | 2008 | 32 | 0.020 |
Why?
|
| Registries | 1 | 2015 | 1579 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2012 | 662 | 0.020 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2008 | 38 | 0.020 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2007 | 11 | 0.020 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2007 | 17 | 0.020 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2007 | 18 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 7105 | 0.020 |
Why?
|
| Ibuprofen | 1 | 2008 | 41 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2007 | 40 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2007 | 97 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 89 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2008 | 172 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2007 | 90 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2007 | 109 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2012 | 984 | 0.020 |
Why?
|
| Water | 1 | 2008 | 195 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 2007 | 97 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2007 | 137 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2007 | 79 | 0.020 |
Why?
|
| Absorption | 1 | 2006 | 51 | 0.020 |
Why?
|
| Drug Compounding | 1 | 2006 | 42 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2007 | 366 | 0.020 |
Why?
|
| Materials Testing | 1 | 2006 | 78 | 0.020 |
Why?
|
| Particle Size | 1 | 2006 | 149 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2006 | 125 | 0.010 |
Why?
|
| RNA Interference | 1 | 2007 | 515 | 0.010 |
Why?
|
| Prognosis | 1 | 2015 | 5008 | 0.010 |
Why?
|
| Transfection | 1 | 2007 | 996 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 688 | 0.010 |
Why?
|
| Risk Factors | 1 | 2019 | 10931 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 1350 | 0.010 |
Why?
|
| Cell Movement | 1 | 2007 | 888 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 1282 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2007 | 605 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 1423 | 0.010 |
Why?
|
| United States | 1 | 2018 | 11655 | 0.010 |
Why?
|
| Hematocrit | 1 | 2002 | 111 | 0.010 |
Why?
|
| Ventricular Function | 1 | 2002 | 91 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2007 | 2679 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 1130 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2002 | 510 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2007 | 4710 | 0.010 |
Why?
|